Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Cancer Research Innovator, Trailblazer, and Mentor Dr. Waun Ki Hong Dies
lungcanc
Ongoing Clinical Challenges: Defining Immunotherapy Benefit for Patients With NSCLC and...
lungcanc
Dr. Fred R. Hirsch Departs IASLC CEO Role, Joins Mount Sinai...
lungcanc
Prophylactic Cranial Irradiation in Locally Advanced NSCLC Falls Flat
lungcanc
FDA Approval Processes in the Era of Targeted Therapies: A Conversation...
lungcanc
Explaining IMpower132: An Interview with Dr. Vassiliki A. Papadimitrakopoulou
lungcanc
The Future Is Now: Pathology Is Going Digital
lungcanc
Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement...
lungcanc
The State of Lung Cancer in Egypt: Progress Is at Hand
lungcanc
Neoadjuvant Nivolumab Shows Unprecedented Pathologic Complete Response for Stage III NSCLC
lungcanc
1
...
19
20
21
...
53
Page 20 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS